JAK2V617F as progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): a comparative study on 1103 CMPD and 269 AML cases.
Standard
JAK2V617F as progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): a comparative study on 1103 CMPD and 269 AML cases. / Schnittger, S; Bacher, Ulrike; Kern, W; Haferlach, T; Haferlach, C.
in: LEUKEMIA, Jahrgang 21, Nr. 8, 8, 2007, S. 1843-1845.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
Schnittger, S, Bacher, U, Kern, W, Haferlach, T & Haferlach, C 2007, 'JAK2V617F as progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): a comparative study on 1103 CMPD and 269 AML cases.', LEUKEMIA, Jg. 21, Nr. 8, 8, S. 1843-1845. <http://www.ncbi.nlm.nih.gov/pubmed/17443220?dopt=Citation>
APA
Schnittger, S., Bacher, U., Kern, W., Haferlach, T., & Haferlach, C. (2007). JAK2V617F as progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): a comparative study on 1103 CMPD and 269 AML cases. LEUKEMIA, 21(8), 1843-1845. [8]. http://www.ncbi.nlm.nih.gov/pubmed/17443220?dopt=Citation
Vancouver
Schnittger S, Bacher U, Kern W, Haferlach T, Haferlach C. JAK2V617F as progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): a comparative study on 1103 CMPD and 269 AML cases. LEUKEMIA. 2007;21(8):1843-1845. 8.
Bibtex
@article{f5f1964cd1a04738a4bab5ef00474dbf,
title = "JAK2V617F as progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): a comparative study on 1103 CMPD and 269 AML cases.",
author = "S Schnittger and Ulrike Bacher and W Kern and T Haferlach and C Haferlach",
year = "2007",
language = "Deutsch",
volume = "21",
pages = "1843--1845",
journal = "LEUKEMIA",
issn = "0887-6924",
publisher = "NATURE PUBLISHING GROUP",
number = "8",
}
RIS
TY - JOUR
T1 - JAK2V617F as progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): a comparative study on 1103 CMPD and 269 AML cases.
AU - Schnittger, S
AU - Bacher, Ulrike
AU - Kern, W
AU - Haferlach, T
AU - Haferlach, C
PY - 2007
Y1 - 2007
M3 - SCORING: Zeitschriftenaufsatz
VL - 21
SP - 1843
EP - 1845
JO - LEUKEMIA
JF - LEUKEMIA
SN - 0887-6924
IS - 8
M1 - 8
ER -
